Effectiveness of BNT162b2 third dose against Omicron-associated severe disease - News-Medical.Net

5/9/2022 12:00:00 AM2 years 11 months ago

Researchers analyzed the effectiveness of the SARS-CoV-2 BNT162b2 third vaccine dose against SARS-CoV-2 Omicron-induced severe infection nearly seven months post-vaccination.

In a recent study posted to the medRxiv* preprint server, researchers analyzed the effectiveness of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BNT162b2 third vaccine dose agains… [+4247 chars]

full article...